Brief: NGM Bio Provides Business Highlights And Reports Q2 Financial Results

NGM Biopharmaceuticals

04/08/2022 22:06

Aug 4 (Reuters) - NGM Biopharmaceuticals Inc  NGM.O :
    * NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
    * CASH, CASH EQUIVALENTS AND SHORT-TERM MARKETABLE SECURITIES WERE $297.8
MILLION
AS OF JUNE 30, 2022
    * REPORTED A NET LOSS OF $46.5 MILLION FOR QUARTER ENDED JUNE 30, 2022
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.59
    * Q2 EARNINGS PER SHARE VIEW $-0.55, REVENUE VIEW $11.9 MILLION -- REFINITIV
IBES
DATA

Source text for Eikon:  ID:nGNXc9z1gH 
Further company coverage:  NGM.O 

 ((Reuters.Briefs@thomsonreuters.com;))